Lv3
250 积分 2025-01-03 加入
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
19天前
已完结
New Molecules and Indications for GLP-1 Medicines
1个月前
已完结
Obesity, diabetes, and inflammation: Pathophysiology and clinical implications
2个月前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
2个月前
已完结
PocketFlow is a data-and-knowledge-driven structure-based molecular generative model
2个月前
已完结
Artificial intelligence in drug development
2个月前
已完结
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
2个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
3个月前
已完结
An exploratory analysis of glucagon‐like peptide‐1 (GLP‐1) agonists and biosimilars: A literature review
3个月前
已完结
Oral Muvalaplin for Lowering of Lipoprotein(a)
3个月前
已完结
皖公网安备34019202002308
